X-inactivation and marker studies in three families with incontinentia pigmenti: Implications for counselling and gene localisation

Clinical Genetics

Volumn 55, Issue 1, 1999, Pages 55-60

  Woffendin, Hayley ^a   Jakins, Tracy ^a   Jouet, Monique ^a   Stewart, Helen ^b   Landy, Sarah ^b   Haan, Eric ^c   Harris, Ann ^d   Donnai, Dian ^b   Read, Andrew ^b   Kenwrick, Sue ^a   Kenwrick, Susan ^e  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Incontinentia pigmenti; Mosaic; X inactivation; Xq28

Indexed keywords

ARTICLE; CHROMOSOME XQ; CLINICAL ARTICLE; FEMALE; GENE LOCATION; GENETIC COUNSELING; GENETIC MARKER; HUMAN; INCONTINENTIA PIGMENTI; PRIORITY JOURNAL; X CHROMOSOME INACTIVATION;

CHROMOSOME MAPPING; DOSAGE COMPENSATION, GENETIC; FEMALE; GENETIC COUNSELING; GENETIC MARKERS; HUMANS; INCONTINENTIA PIGMENTI; MALE; PEDIGREE; RECOMBINATION, GENETIC; X CHROMOSOME;

EID: 0032944553     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.1999.550110.x     Document Type: Article

References (13)

1. Landy SJ, Donnai D. Incontinentia pigmenti (Bloch Sulzberger syndrome). J Med Genet 1993: 30: 53-59.
2. Sefiani A, Abel L, Heuertz S, Sinnett D, Lavergne L, Labuda D, Hors-Cayla MC. The gene for incontinentia pigmenti is assigned to Xq28. Genomics 1989: 4: 427-429.
3. Sefiani A, M'rad R, Simard L, Vincent A, Julier C, Holvoet-Vermaut L, Heuertz S, Dahl N, Stalder JF, Peter MO, Moraine C, Maleville J, Boyer J, Oberlé I, Labuda D, Hors-Cayla MC. Linkage relationship between incontinentia pigmenti (IP2) and nine terminal X long arm markers. Hum Genet 1991: 86: 297-299.
4. Smahi A, Hyden-Granskog C, Peterlin B, Vabres P, Heuertz S, Fulchignoni-Lataud MC, Dahl N, Labrune P, Marec BL, Puissan C, Taieb A, von Koskull H, Hors-Cayla MC. The gene for the familial form of incontinentia pigmenti (IP2) maps to the distal part of Xq28. Hum Mol Genet 1994: 3: 273-278.
5. Parrish JE, Scheuerle AE, Lewis RA, Levy ML, Nelson D. Selection against mutant alleles in blood leukocytes in a consistent feature in incontinentia pigmenti type 2. Hum Mol Genet 1996: 5: 1777-1783.
6. Jouet M, Stewart H, Landy S, Yates J, Yong SL, Harris A, Garret C, Hatchwell E, Read A, Donnai D, Kenwrick S. Linkage analysis in 16 families with incontinentia pigmenti. Eur J Hum Genet 1997: 5: 168-170.
7. Migeon BR, Axelman J, de Beur SJ, Valle D, Mitchell GA, Rosenbaum KN. Selection against lethal alleles in female heterozygous for incontinentia pigmenti. Am J Hum Genet 1989: 44: 100-106.
8. Harris A, Collins J, Vetrie D, Cole C, Bobrow M. X-inactivation as a mechanism of selection against lethal alleles: further investigation of incontinentia pigmenti and X-linked lymphoproliferative disease. J Med Genet 1992: 29: 608-614.
9. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of Hpa II and Hha I sites near the polymorphic CAG repeat in the human androgen receptor gene correlates with X chromosome inactivation. Am J Med Genet 1992: 51: 1229-1239.
10. Jouet M, Rosenthal A, Armstrong G, MacFarlane J, Stevenson R, Paterson J, Metzenberg A, Ionasescu V, Temple K, Kenwrick S. X-linked spastic paraplegia (SPG1). MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene. Nat Genet 1994: 7: 402-407.
11. Traup H, Vehring KH. Unstable premutation may explain mosaic disease expression of incontinentia pigmenti in males. Am J Med Genet 1994: 49: 397-398.
12. Hatchwell E. Unstable premutation in incontinentia pigmenti. J Med Genet 1996: 33: 349-350.
13. Hyden-Granskog C, Salonen R, von Koskull H. Three Finnish incontinentia pigmenti (IP) families with recombinations with the IP loci at Xq28 and Xp11. Hum Genet 1993: 91: 185-189.